期刊文献+

非何杰金淋巴瘤侵犯椎管内神经根1例报告

下载PDF
导出
摘要 非何杰金淋巴瘤侵犯椎管内神经根罕见,我院收治1例,报告如下。患者男性,50岁,2005年11月始出现下肢疼痛,沿大腿至足跟外侧,口服镇痛药可暂时缓解,疼痛呈进行性加重,10d前出现剧痛,需肌注曲马多缓解,于2006年2月26日收入院。查体:生命体征正常,体表淋巴结未扪及,心肺止常,肝脾未扪及。
出处 《中国脊柱脊髓杂志》 CAS CSCD 2007年第6期479-479,I0002,共2页 Chinese Journal of Spine and Spinal Cord
  • 相关文献

参考文献1

二级参考文献17

  • 1[1]Jaffe ES,Harris NL,Stein H,et al.World Health Organization Classification of tumors.Pathology and genetics of tumours of haematopoietic and lymphoid tissues.Lyon,France:IARC Press,2001
  • 2[2]DeVita VT Jr,Canellos GP,Chabner B,et al.Advanced diffuse histiocytic lymphoma:A potentially curable disease,Lancet,1975,1:248
  • 3[3]Fisher RI,Gaynor ER,Dahlberg S,et al.Comparison of a standar regimem (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.N Engl J Med,1993,328:1002
  • 4[4]Linch DC,Vaughan Hudson B,Hancock BW,et al.A randomized comparison of a third-generation regimen (PACEBOM)with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma:A British National Lymphoma Investigation report.Br J Cancer,1996,74:318
  • 5[5]Pfreundschuh M,Truemper L,Kloess M,et al.2-weekly vs 3-weekly CHOP with and without etoposide for patients > 60 years of age with aggressive non-Hodgkin's lymphoma (NHL):Results of the completed NHL-B-2 trial of the DSHNHL.Blood,2004,104:634
  • 6[6]Tilly H,Lepage E,Coiffer B,et al.Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin's lymphoma.Blood,2003,102:4284
  • 7[8]Coiffier B,Haioun C,Ketterer N,et al.Rituximab (antiCD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma:A multicenter phase Ⅱ study.Blood,1998,92:1927
  • 8[9]Vose JM,Link BK,Grossbard ML,et al.Phase Ⅱ study of rituximab in combination with CHOP chemotherapy in patients with previously untreated,aggressive non-Hodgkin's lymphoma.J Clin Oncol,2001,19:389
  • 9[10]Vose JM,Link BK,Grossbard ML,et al.Long term follow-up of a phase Ⅱ study of rituximab in combination with CHOP chemotherapy in patients with previously untreated aggressive non-Hodgkin's lymphoma (NHL).Blood,2002,100:36A
  • 10[11]Sehn LH,Jane Donaldson J,Chhanabhai M,et al.Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.J Clin Oncol,2005,23:5027

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部